What Vaccine Trials?



Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19in Healthy Individuals

First Posted  : April 30, 2020
Last Update Posted  : January 12, 2021
No results posted
Actual Study Start Date  : April 29, 2020
Estimated Primary Completion Date  : July 30, 2021
Estimated Study Completion Date  : January 27, 2023


My understanding is  that not even phase 1 has been completed so people are participating  in live experiment without informed consent . 

The  trick they used is a half truth – ‘ Estimated Primary Completion Date  : July 30, 2021’ to claim that trials were done.

Under secondary outcome ,

They use phase 1 – central laboratory measures for follow up, phase 2/3 only 1000 people follow up and in 2 younger age groups only 1 month follow-up after 2nd dose.

Phase 1 participants, [ Time Frame: Through 2 years after the final dose ]
As measured at the central laboratory

Phase 2/3 participants [ Time Frame: From 7 days after the second dose of study intervention to the end of the study, up to 2 years ]
Per 1000 person-years of follow-up

Phase 2/3 participants [ Time Frame: From 14 days after the second dose of study intervention to the end of the study, up to 2 years ]
Per 1000 person-years of follow-up

GMR of SARS CoV 2 neutralizing titers in the 2 age groups (12-15 years of age to 16-25 years of age) [ Time Frame: 1 month after the second dose ]
As measured at the central laboratory



From offguardian- What Vaccine Trials?



The main point is this. If you decide to have Pfizer and BioNTech’s experimental mRNA-based BNT162b2 (BNT) vaccine, or any other claimed COVID 19 vaccine for that matter, you are a test subject in a drug trial.

When investigator Fran Leader questioned Pfizer they confirmed:
The DNA template does not come directly from an isolated virus from an infected person.
Nor are there any completed clinical trials for these vaccines. Trials are ongoing. If you are jabbed with one, you are the guinea pig. 

They have not concluded their phase three trials. They haven’t even fully completed phase one.

The fact that there are no completed clinical trials for the Pfizer and BioNTech BNT vaccine also explains why the FDA State:

Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.

The FDA also noted:

[There is]…currently insufficient data to make conclusions about the safety of the vaccine in sub-populations such as children less than 16 years of age, pregnant and lactating individuals, and immunocompromised individuals…..[the] risk of vaccine-enhanced disease over time, potentially associated with waning immunity, remains unknown.

Yet the first people to receive this vaccine are the most vulnerable in society, many of whom are immunocompromised. The precautionary principle appears to have been abandoned. The notion that the purpose of the BNT vaccine roll out is to save life appears untenable.

Recently the UK Financial Times reported that the UK regulators (the MHRA) are due to approve Astrazeneca/Oxfords AZD1222 [ChAdOx1] COVID 19 Vaccine.
Thus giving the public the impression that the trials are complete and that the regulators have strict safety standards. The 1,2,3 phase trial for AZD1222 was registered with the U.S. Centre for Disease Control as clinical trial NCT04516746 [Archived 29th December 2020]. It is incomplete and the estimated end date is February 21st 2023. The CDC state:

No Study Results Posted

Astrazeneca are years away from reporting any “final data.” It is impossible for the UK Department of Health to review it, because it doesn’t exist.

No votes yet